Another important concept is synthetic lethality. This occurs when the simultaneous disruption of two genes leads to cell death, whereas disrupting only one of these genes does not. Cancer cells often have mutations that make them particularly vulnerable to the loss of a second gene. By identifying and targeting these vulnerabilities, therapies can selectively kill cancer cells while sparing normal cells.
